A new oral contraceptive with a 7 plus 15 sequential formulation.
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004357:Drug Synergism; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D004717:Endometrium / Q000187:drug effects*; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007989:Libido / Q000187:drug effects; D008111:Liver Function Tests; D008234:Lynestrenol / Q000009:adverse effects* / Q000494:pharmacology*; D008599:Menstruation Disturbances / Q000139:chemically induced; D008656:Mestranol / Q000009:adverse effects* / Q000494:pharmacology*; D049590:Postpartum Period; D011247:Pregnancy; D014626:Vaginal Smears
D003276:Contraceptives, Oral; D008656:Mestranol; D008234:Lynestrenol